Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cara Haymaker"'
Autor:
Funda Meric-Bernstam, Alan E. Siroy, Agda Karina Eterovic, Lauren E. Haydu, Kenna R. Shaw, Kenneth R. Hess, Patrick Hwu, Cara Haymaker, Laszlo Radvanyi, Jie Qing Chen, Gordon B. Mills, Aron Y. Joon, Marie Andrée Forget, Chantale Bernatchez, Francesco C. Stingo, Jennifer A. Wargo, Alexander J. Lazar, Michael A. Davies, Michael T. Tetzlaff, Don L. Gibbons, Junna Oba, Scott E. Woodman, Ken Chen, P. Andrew Futreal, Veerabhadran Baladandayuthapani, Tatiana Karpinets, Jeffrey E. Gershenwald, Jason Roszik
Publikováno v:
BMC Medicine
Background While clinical outcomes following immunotherapy have shown an association with tumor mutation load using whole exome sequencing (WES), its clinical applicability is currently limited by cost and bioinformatics requirements. Methods We deve
Autor:
Amir A. Jazaeri, Marie-Andree Forget, Cara Haymaker, Chantale Bernatchez, Donastas Sakellariou-Thompson, Patrick Hwu
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Immunotherapy has become an effective cancer therapy, particularly in the case of checkpoint blockade and adoptive T cell therapy (ACT). ACT exploits the presence of tumor-infiltrating lymphocytes (TIL) by exponentially expanding th
Autor:
Krit Ritthipichai, Chantale Bernatchez, Patrick Hwu, Cara Haymaker, Caitlin Creasy, Marie-Andree Forget
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Adoptive T cell therapy using tumor-infiltrating lymphocytes (TIL) for patients with metastatic melanoma has been shown to have a 45-50% response rate as demonstrated by multiple institutions worldwide. However, understanding how lo
Autor:
Melisa Martinez-Paniagua, Laszlo Radvanyi, Jay R Adolacion, Cara Haymaker, Navin Varadarajan, Badrinath Roysam, Patrick Hwu, Chantale Bernatchez
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Adoptive cell therapy (ACT) of tumor infiltrating lymphocytes (TIL) has shown the ability to induce complete regression of stage IV melanoma. Two challenges associated TIL ACT are that (i) T cells are capable of different anti-tumor
Autor:
Scott E. Woodman, Isabella C. Glitza, Wen-Jen Hwu, Cassian Yee, Dae Won Kim, Christine N. Spencer, Chantale Bernatchez, Jennifer A. Wargo, Alda L. Tam, Patrick Hwu, James P. Allison, Rodabe N. Amaria, Elizabeth Sirmans, Padmanee Sharma, Michael Davies, Natalie McQuail, Cara Haymaker, Sapna Pradyuman Patel, Adi Diab
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Cryo is an effective modality for pain palliation and local control of soft tissue and bone metastases. Cryo induces necrotic cell death, and combination cryo with anti-CTLA-4 generates potent systemic anti-tumor immune responses in
Autor:
P. Hwu, Cara Haymaker, Jieqing Chen, Laszlo Radvanyi, Suhendan Ekmekcioglu, Carlos A. Torres-Cabala, Jianhua Hu, Sourindra Maiti, Wencai Ma, Chantale Bernatchez, R. Eric Davis, Charuta Kale, Roland L. Bassett, Zhiqiang Wang, Jason Roszik, Caitlin Creasy
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Adoptive cell therapy using autologous TIL is a promising immunotherapy for metastatic melanoma. This study was aimed at finding predictive biomarkers in TIL patients, using IHC and gene expression analysis on original tumors used t